As shown in Figure 9A and Supplementary Figure 2A, we found that the somatic mutation frequency of NKCC1 mutation was 0.995% and KCC2 mutation was 1.96% among 48,834 pan-cancer samples from 66 databases. This evidence concerns the gene SLC12A2 and cancer.